Kitov Pharmaceuticals Holdings Ltd., through its subsidiary, Kitov Pharmaceuticals Ltd., operates as a clinical development stage biopharmaceutical company. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The company's lead drug candidate is KIT-302, a fixed dosage combination product based on the generic drugs celecoxib and amlodipine besylate that has completed its Phase III clinical study. It is also developing KIT-301, which is based on the generic drugs naproxen and isradipine. . The company was formerly known as Mainrom Line Logistics Ltd. and changed its name to Kitov Pharmaceuticals Holdings Ltd. in August 2013. Kitov Pharmaceuticals Holdings Ltd. was incorporated in 1968 is based in Tel Aviv, Israel.
http://www.priceseries.com/trade/KTOV-Kitov-Pharamceuticals-Holdings-Ltd-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017071920170803.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments